Integral Ad Science’s (IAS) Hold Rating Reaffirmed at Benchmark

Benchmark reiterated their hold rating on shares of Integral Ad Science (NASDAQ:IAS) in a research note released on Thursday,Benzinga reports.

A number of other brokerages have also recently issued reports on IAS. Raymond James lifted their price target on shares of Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Craig Hallum decreased their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday. Oppenheimer decreased their target price on shares of Integral Ad Science from $20.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday. Truist Financial decreased their target price on shares of Integral Ad Science from $18.00 to $16.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Barclays lifted their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Monday, August 5th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $15.70.

Integral Ad Science Stock Down 5.9 %

NASDAQ IAS traded down $0.64 during trading hours on Thursday, reaching $10.13. 1,741,442 shares of the company’s stock traded hands, compared to its average volume of 1,392,231. Integral Ad Science has a 52-week low of $7.98 and a 52-week high of $17.53. The firm has a market cap of $1.65 billion, a PE ratio of 50.60, a PEG ratio of 1.46 and a beta of 1.52. The firm has a 50-day simple moving average of $11.11 and a 200 day simple moving average of $10.47. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.76.

Integral Ad Science (NASDAQ:IAS) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The company had revenue of $133.50 million during the quarter, compared to analysts’ expectations of $138.06 million. During the same period last year, the company posted ($0.09) EPS. Integral Ad Science’s revenue was up 11.0% on a year-over-year basis. Sell-side analysts anticipate that Integral Ad Science will post 0.25 EPS for the current fiscal year.

Insider Transactions at Integral Ad Science

In related news, CFO Tania Secor sold 5,240 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $52,976.40. Following the completion of the sale, the chief financial officer now directly owns 248,223 shares in the company, valued at approximately $2,509,534.53. The trade was a 2.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Lisa Utzschneider sold 10,481 shares of the business’s stock in a transaction that occurred on Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $105,962.91. Following the sale, the chief executive officer now owns 239,709 shares of the company’s stock, valued at $2,423,457.99. This trade represents a 4.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 23,006 shares of company stock worth $240,296 over the last three months. 2.00% of the stock is currently owned by company insiders.

Institutional Trading of Integral Ad Science

Several large investors have recently added to or reduced their stakes in the business. Jupiter Asset Management Ltd. bought a new position in shares of Integral Ad Science in the first quarter worth approximately $3,257,000. Clearline Capital LP bought a new position in shares of Integral Ad Science in the second quarter worth approximately $916,000. abrdn plc boosted its position in shares of Integral Ad Science by 12.5% in the third quarter. abrdn plc now owns 2,147,656 shares of the company’s stock worth $23,216,000 after purchasing an additional 237,930 shares during the period. Jacobs Levy Equity Management Inc. boosted its position in shares of Integral Ad Science by 4.7% in the first quarter. Jacobs Levy Equity Management Inc. now owns 1,246,556 shares of the company’s stock worth $12,428,000 after purchasing an additional 55,844 shares during the period. Finally, Clearbridge Investments LLC boosted its position in shares of Integral Ad Science by 11.8% in the first quarter. Clearbridge Investments LLC now owns 3,906,652 shares of the company’s stock worth $38,949,000 after purchasing an additional 412,044 shares during the period. 95.78% of the stock is currently owned by institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.